Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Evolus Inc
(NQ:
EOLS
)
15.86
+0.38 (+2.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evolus Inc
< Previous
1
2
3
4
5
6
Next >
Final Phase 2 Data Evaluating 40U Dose of PrabotulinumtoxinA-xvfs to be Presented at 2023 ASDS Annual Meeting
October 25, 2023
From
Evolus
Via
Business Wire
7 Must-Own Small-Cap Stocks That Could Outperform the Market
October 08, 2023
If you’re ready to absorb significant risk for the chance of ridiculous upside, these small-cap stocks to buy may be just for you.
Via
InvestorPlace
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 29, 2023
From
Evolus
Via
Business Wire
7 Small-Cap Stocks Analysts Predict Will Double in 2024
September 13, 2023
While small-cap stocks to buy present exceptional risk, they also offer tremendous rewards for intrepid retail investors.
Via
InvestorPlace
Earnings Preview: Evolus
August 01, 2023
Via
Benzinga
5 Analysts Have This to Say About Evolus
July 28, 2023
Via
Benzinga
Evolus Inc. (NASDAQ: EOLS) Highlighted for Surprising Price Action
July 27, 2023
Via
Investor Brand Network
Evolus to Participate in September Conferences
August 29, 2023
From
Evolus
Via
Business Wire
Evolus Announces Inducement Grants for New Chief Marketing Officer
August 23, 2023
From
Evolus
Via
Business Wire
Evolus Appoints Tomoko Yamagishi-Dressler as Chief Marketing Officer
August 21, 2023
From
Evolus
Via
Business Wire
Over $15M Bet On Impinj? Check Out These 4 Stocks Insiders Are Buying
August 16, 2023
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
Why Shares of Evolus Are Jumping Thursday
July 27, 2023
The stock climbed on record second-quarter revenue and a raise in full-year guidance.
Via
The Motley Fool
Expert Ratings for Evolus
May 26, 2023
Via
Benzinga
This Analyst Likes Evolus As 'Top Play In Aesthetics'
May 10, 2023
Evolus Inc (NASDAQ: EOLS) will be the exclusive U.S.
Via
Benzinga
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
August 08, 2023
Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the...
Via
Newsfile
Evolus Unveils New Branding for Flagship Product Jeuveau® to Reflect Growing and Evolving Consumers
August 08, 2023
From
Evolus
Via
Business Wire
Evolus Reports Second Quarter 2023 Results and Provides Business Update
August 02, 2023
From
Evolus
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
July 27, 2023
Via
Benzinga
Expert Ratings for Evolus
May 10, 2023
Via
Benzinga
Evolus: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 27, 2023
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
Via
Benzinga
Comcast, STMicroelectronics, Lam Research, Meta Platforms And Other Big Stocks Moving Higher On Thursday
July 27, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue
July 27, 2023
From
Evolus
Via
Business Wire
Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference
July 26, 2023
From
Evolus, Inc.
Via
Business Wire
Evolus to Report Second Quarter 2023 Results and Provide Business Update
July 19, 2023
From
Evolus
Via
Business Wire
Twitter Faces Threats From AI and Threads
July 15, 2023
AI is changing the open internet landscape, and Meta's new Threads app is looking to take a bite out of Twitter's audience.
Via
The Motley Fool
Evolus Launches Nuceiva® (botulinum toxin type A) in Italy
June 29, 2023
From
Evolus
Via
Business Wire
Evolus Announces Successful Completion of Phase 2 Study Evaluating “Extra-Strength” Dose of Jeuveau ®
June 22, 2023
From
Evolus
Via
Business Wire
Evolus Reaches 1 Million Redemptions in its Evolus Rewards™ Patient Loyalty Program
June 08, 2023
From
Evolus
Via
Business Wire
Evolus Reports First Quarter 2023 Results and Provides Business Update
May 09, 2023
From
Evolus
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.